Adiponectin promotes muscle regeneration through binding to T-cadherin

[1]  前田 聡美.  Serum albumin/globulin ratio is associated with cognitive function in community-dwelling older people:The Septuagenarians, Octogenarians, Nonagenarians Investigation with Centenarians study , 2020 .

[2]  H. Rakugi,et al.  High plasma adiponectin levels are associated with frailty in a general old‐old population: The Septuagenarians, Octogenarians, Nonagenarians Investigation with Centenarians study , 2018, Geriatrics & gerontology international.

[3]  E. Fukusaki,et al.  Adiponectin/T-cadherin system enhances exosome biogenesis and decreases cellular ceramides by exosomal release. , 2018, JCI insight.

[4]  A. Pagnani,et al.  Somatic mutagenesis in satellite cells associates with human skeletal muscle aging , 2018, Nature Communications.

[5]  S. Smaili,et al.  Reduction in skeletal muscle fibrosis of spontaneously hypertensive rats after laceration by microRNA targeting angiotensin II receptor , 2017, PloS one.

[6]  S. Brichard,et al.  Potential Therapeutic Action of Adiponectin in Duchenne Muscular Dystrophy. , 2017, The American journal of pathology.

[7]  T. Funahashi,et al.  The unique prodomain of T-cadherin plays a key role in adiponectin binding with the essential extracellular cadherin repeats 1 and 2 , 2017, The Journal of Biological Chemistry.

[8]  T. Funahashi,et al.  Adiponectin association with T‐cadherin protects against neointima proliferation and atherosclerosis , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  I. Komuro,et al.  Angiotensin II receptor blockade promotes repair of skeletal muscle through down-regulation of aging-promoting C1q expression , 2015, Scientific Reports.

[10]  B. Viollet,et al.  Obesity Impairs Skeletal Muscle Regeneration Through Inhibition of AMPK , 2015, Diabetes.

[11]  S. Brichard,et al.  Involvement of adiponectin in the pathogenesis of dystrophinopathy , 2015, Skeletal Muscle.

[12]  M. Yandell,et al.  Muscle stem cells contribute to myofibers in sedentary adult mice , 2015, Nature Communications.

[13]  田原 康玄,et al.  生活習慣病とgenome-wide association study , 2015 .

[14]  T. Funahashi,et al.  Positive feedback regulation between adiponectin and T-cadherin impacts adiponectin levels in tissue and plasma of male mice. , 2015, Endocrinology.

[15]  Lin Yang,et al.  Inducible depletion of satellite cells in adult, sedentary mice impairs muscle regenerative capacity but does not contribute to sarcopenia , 2014, Nature Medicine.

[16]  O. MacDougald,et al.  Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction. , 2014, Cell metabolism.

[17]  Nicolas A. Dumont,et al.  Inhibition of JAK/STAT signaling stimulates adult satellite cell function , 2014, Nature Medicine.

[18]  T. Funahashi,et al.  Effect of adiponectin on cardiac β-catenin signaling pathway under angiotensin II infusion. , 2014, Biochemical and biophysical research communications.

[19]  M. Lainscak,et al.  Association of adiponectin with peripheral muscle status in elderly patients with heart failure. , 2013, European journal of internal medicine.

[20]  Y. Teo,et al.  Genetic Variation in CDH13 Is Associated With Lower Plasma Adiponectin Levels but Greater Adiponectin Sensitivity in East Asian Populations , 2013, Diabetes.

[21]  Y. Matsuzawa,et al.  Relationship between serum adiponectin levels and age in healthy subjects and patients with type 2 diabetes , 2013, Clinical endocrinology.

[22]  P. Delafontaine,et al.  Angiotensin II Inhibits Satellite Cell Proliferation and Prevents Skeletal Muscle Regeneration* , 2013, The Journal of Biological Chemistry.

[23]  Ryosuke Kikuchi,et al.  T-cadherin Is Essential for Adiponectin-mediated Revascularization* , 2013, The Journal of Biological Chemistry.

[24]  L. Chuang,et al.  Plasma Adiponectin Levels Correlate Positively with an Increasing Number of Components of Frailty in Male Elders , 2013, PloS one.

[25]  A. Wagers,et al.  Skeletal muscle degenerative diseases and strategies for therapeutic muscle repair. , 2013, Annual review of pathology.

[26]  Y. Kokubo,et al.  CDH13 gene coding t‐cadherin influences variations in plasma adiponectin levels in the Japanese population , 2012, Human mutation.

[27]  M. Montagnana,et al.  A variant upstream of the CDH13 adiponectin receptor gene and metabolic syndrome in Swedes. , 2011, The American journal of cardiology.

[28]  Wen-Harn Pan,et al.  A Genome-Wide Association Study Reveals a Quantitative Trait Locus of Adiponectin on CDH13 That Predicts Cardiometabolic Outcomes , 2011, Diabetes.

[29]  T. Koh,et al.  Impaired Muscle Regeneration in Ob/ob and Db/db Mice , 2011, TheScientificWorldJournal.

[30]  H. Hirose,et al.  Serum high-molecular-weight adiponectin as a marker for the evaluation and care of subjects with metabolic syndrome and related disorders. , 2010, Journal of atherosclerosis and thrombosis.

[31]  P. Ruiz-Lozano,et al.  T-cadherin is critical for adiponectin-mediated cardioprotection in mice. , 2010, The Journal of clinical investigation.

[32]  T. Beaty,et al.  Adiponectin concentrations: a genome-wide association study. , 2010, American journal of human genetics.

[33]  Hiroshi Yamamoto,et al.  Genetic background affects properties of satellite cells and mdx phenotypes. , 2010, The American journal of pathology.

[34]  K. Shimamoto,et al.  [The Tanno and Sobetsu study]. , 2010, Nihon rinsho. Japanese journal of clinical medicine.

[35]  A. Uezumi,et al.  Suppression of macrophage functions impairs skeletal muscle regeneration with severe fibrosis. , 2008, Experimental cell research.

[36]  S. Kihara,et al.  Adiponectin Protects Against Angiotensin II–Induced Cardiac Fibrosis Through Activation of PPAR-&agr; , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[37]  Toshihiko Uchida,et al.  High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease. , 2007, The American journal of cardiology.

[38]  R. Rizza,et al.  Selective Downregulation of the High–Molecular Weight Form of Adiponectin in Hyperinsulinemia and in Type 2 Diabetes , 2007, Diabetes.

[39]  Vineet Chopra,et al.  Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. , 2006, European heart journal.

[40]  Ratan D. Bhardwaj,et al.  Retrospective Birth Dating of Cells in Humans , 2005, Cell.

[41]  S. Takagi,et al.  Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study. , 2005, European journal of endocrinology.

[42]  J. Chudek,et al.  Ageing and plasma adiponectin concentration in apparently healthy males and females , 2005, Clinical endocrinology.

[43]  P. Froguel,et al.  Impaired Multimerization of Human Adiponectin Mutants Associated with Diabetes , 2003, Journal of Biological Chemistry.

[44]  J. Engel,et al.  Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectin , 2003, The Journal of Biological Chemistry.

[45]  S. Orimo,et al.  Analysis of inflammatory cells and complement C3 in bupivacaine‐induced myonecrosis , 1991, Muscle & nerve.

[46]  Feodor Price,et al.  Satellite cells and the muscle stem cell niche. , 2013, Physiological reviews.

[47]  M. Sinha,et al.  Skeletal muscle stem cells: effects of aging and metabolism on muscle regenerative function. , 2011, Cold Spring Harbor symposia on quantitative biology.

[48]  S. Yaturu,et al.  Plasma and urine levels of resistin and adiponectin in chronic kidney disease. , 2007, Cytokine.